Literature DB >> 10746906

Subclinical cognitive impairment: epidemiology and clinical characteristics.

K Ritchie1, B Ledésert, J Touchon.   

Abstract

Subclinical cognitive impairment is commonly reported in elderly populations, but its clinical significance is largely undetermined. It is commonly perceived as a normal feature of the aging process or a separate nosological entity. The clinical status of this disorder is explored herein by reference to longitudinal observations. It is concluded that persons with subclinical cognitive impairment constitute a highly heterogeneous group. There is an elevated risk in this group for senile dementia, with an estimated 18% incidence rate over 3 years, but in the majority of cases, this problem is more commonly associated with depressive symptomatology and physical illness. Only 13% of persons with recent observable change in cognitive functioning appear to have a totally benign and transient syndrome. Caution should be exercised in applying single unifying nosological entities such as age-associated memory impairment to this group of the elderly.

Entities:  

Mesh:

Year:  2000        PMID: 10746906     DOI: 10.1016/s0010-440x(00)80010-3

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  8 in total

1.  Effects of white matter integrity and brain volumes on late life depression in the Framingham Heart Study.

Authors:  Wei Qiao Qiu; Jayandra J Himali; Philip A Wolf; D Charles DeCarli; Alexa Beiser; Rhoda Au
Journal:  Int J Geriatr Psychiatry       Date:  2016-04-05       Impact factor: 3.485

2.  Amyloid-associated depression: a prodromal depression of Alzheimer disease?

Authors:  Xiaoyan Sun; David C Steffens; Rhoda Au; Marshal Folstein; Paul Summergrad; Jacqueline Yee; Irwin Rosenberg; D Mkaya Mwamburi; Wei Qiao Qiu
Journal:  Arch Gen Psychiatry       Date:  2008-05

3.  Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.

Authors:  Wei Qiao Qiu; Haihao Zhu; Michael Dean; Zhiheng Liu; Linh Vu; Guanguang Fan; Huajie Li; Mkaya Mwamburi; David C Steffens; Rhoda Au
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-06       Impact factor: 3.485

4.  Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.

Authors:  Marta Encinas; Ramón De Juan; Alberto Marcos; Pedro Gil; Ana Barabash; Cristina Fernández; Carmen De Ugarte; José Antonio Cabranes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-15       Impact factor: 9.236

5.  Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.

Authors:  Xiaoyan Sun; Chi Chia Chiu; Elizabeth Liebson; Natalia A Crivello; Lixia Wang; Joshua Claunch; Marshal Folstein; Irwin Rosenberg; D Mkaya Mwamburi; Inga Peter; Wei Qiao Qiu
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

6.  Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study.

Authors:  Katie Palmer; Lars Bäckman; Bengt Winblad; Laura Fratiglioni
Journal:  BMJ       Date:  2003-02-01

7.  Hormones and dementia - a comparative study of hormonal impairment in post-menopausal women, with and without dementia.

Authors:  Olívia Robusto-Leitao; H Ferreira
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

8.  A new Brief computerized cognitive screening battery (CompCogs) for early diagnosis of Alzheimer's disease.

Authors:  Helenice Charchat Fichman; Ricardo Nitrini; Paulo Caramelli; Koichi Sameshima
Journal:  Dement Neuropsychol       Date:  2008 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.